Literature DB >> 2438356

Ia antigen expressed by keratinocytes can be the molecule of antigen presentation in contact sensitivity.

K Nishioka, I Katayama, Y Kobayashi.   

Abstract

Immune response-associated (Ia) antigens are important as molecules in antigen recognition by T cells. Keratinocytes can express Ia antigens in many inflammatory dermatoses and by action of gamma interferon (IFN-gamma). A keratinocyte cell line, Pam 212 cells, expressed Ia antigens at maintaining culture. They also expressed Ia antigens under the influence of IFN-gamma. Liposomes carrying molecules from trinitrophenylated-Pam cells did not stimulate lymphnode cells (LCs) of contact sensitivity; however, liposomes carrying a large amount of those molecules stimulated LCs. This stimulation was attributable to contaminated Ia antigens in those molecules. Liposomes with a small amount of those molecules or trinitrophenylated-proteins from Pam cells were prepared. Into them were inserted Ia antigen-rich proteins from Pam cells, spleen cells, IFN-gamma-treated Pam cells, or epidermal cells containing Langerhans cells. Thus prepared liposomes stimulated the LCs significantly. The Ia antigens obtained from IFN-gamma-treated Pam cells worked as well as Ia antigens from epidermal cells that contained Langerhans cells as the molecule of antigen presentation in contact sensitivity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438356     DOI: 10.1111/1523-1747.ep12470371

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  2 in total

1.  Epidermal Langerhans cells, dermal dendritic cells, and keratinocytes in viral lesions of skin and mucous membranes: an immunohistochemical study.

Authors:  M Drijkoningen; C De Wolf-Peeters; H Degreef; V Desmet
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

2.  Regulation of contact hypersensitivity by interleukin 10.

Authors:  T A Ferguson; P Dube; T S Griffith
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.